Ocular graft-versus-host disease (oGVHD): From A to Z

M Soleimani, PM Sharif, K Cheraqpour, R Koganti… - Survey of …, 2023 - Elsevier
Allogeneic hematopoietic stem cell transplantation is a definitive therapy for a variety of
disorders. One of the complications is acute graft-versus-host disease (aGVHD), which has a …

Ocular graft-versus-host disease (oGVHD): From A to Z.

M Soleimani, PM Sharif, K Cheraqpour… - Survey of …, 2023 - europepmc.org
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a definitive therapy for a
variety of disorders. One of the complications is acute graft-versus-host disease (aGVHD) …

Ocular graft-versus-host disease (oGVHD): From A to Z

M Soleimani, PM Sharif, K Cheraqpour… - Survey of …, 2023 - surveyophthalmol.com
Allogeneic hematopoietic stem cell transplantation is a definitive therapy for a variety of
disorders. One of the complications is acute graft-versus-host disease (aGVHD), which has a …

Ocular graft-versus-host disease (oGVHD): From A to Z

M Soleimani, PM Sharif… - Survey of …, 2023 - pubmed.ncbi.nlm.nih.gov
Allogeneic hematopoietic stem cell transplantation is a definitive therapy for a variety of
disorders. One of the complications is acute graft-versus-host disease (aGVHD), which has a …